1. Pharmaceuticals:
- Anticholinergic Medications: Anticholinergic medications are commonly prescribed for the treatment of overactive bladder. These medications help to relax the bladder muscles, reduce urinary frequency, and improve urinary incontinence. They block the effects of acetylcholine, a neurotransmitter responsible for bladder contractions. Anticholinergic medications such as oxybutynin, tolterodine, and solifenacin are widely used for overactive bladder treatment.
2. Neurostimulation Devices:
- Sacral Nerve Stimulation: This advanced treatment option involves the use of a device that delivers electrical impulses to the sacral nerves, located near the base of the spine. The electrical stimulation helps to modulate the signals sent between the bladder and the brain, resulting in improved bladder control. Sacral nerve stimulation is a minimally invasive procedure that offers long-term relief for patients with overactive bladder symptoms.
3. Behavior Modification Techniques:
- Bladder Training: Bladder training is a common behavior modification technique used in the management of overactive bladder. It involves specific strategies to increase the time interval between urination and gradually increase bladder capacity. This technique helps patients regain control over their bladder and reduce urinary urgency and frequency.
The overactive bladder treatment market is highly competitive and consists of several major players. Some of the prominent companies operating in the market include Astellas Pharma Inc., Pfizer, Inc., Allergan plc, Mylan N.V., Astellas Pharma Inc., Teva Pharmaceutical Industries Ltd., Hisamitsu Pharmaceutical Co., Inc., and others. These players focus on various strategies such as mergers and acquisitions, collaborations, and new product developments to strengthen their market position and expand their product portfolios. Additionally, they invest in research and development activities to introduce innovative treatment options for overactive bladder.